Report cover image

Diabeloop SA - Product Pipeline Analysis, 2023 Update

Publisher GlobalData
Published Apr 04, 2024
Length 34 Pages
SKU # GBDT18719552

Description

Summary


Diabeloop SA (Diabeloop) is a medtech company that designs and develops artificial intelligence (AI) based next generation automated insulin delivery system for Type-1 diabetes. The company’s DBLG1, an external medical device is based on a self-learning algorithm hosted in a handset and connected with a continuous glucose measurement system and an insulin patch pump. It calculates and analyzes real time data and provides dose of insulin to administer based on patient’s physiology, history and data entries. Diabeloop employs YourLoops, a web platform for data visualization which records, stores and shares the patient’s data to healthcare providers. It works in collaboration with Centre for Studies and Research for the Intensification of Diabetes Treatment (CERITD), public medical centers, and CEA-Leti for advancing its products. Diabeloop is headquartered in Grenoble, Auvergne, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Diabeloop SA
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

34 Pages
Diabeloop SA Company Overview
Diabeloop SA Company Snapshot
Diabeloop SA Pipeline Products and Ongoing Clinical Trials Overview
Diabeloop SA – Pipeline Analysis Overview
Diabeloop SA - Key Facts
Diabeloop SA - Major Products and Services
Diabeloop SA Pipeline Products by Development Stage
Diabeloop SA Ongoing Clinical Trials by Trial Status
Diabeloop SA Pipeline Products Overview
Automated Insulin Delivery System
Automated Insulin Delivery System Product Overview
DBL-4pen
DBL-4pen Product Overview
DBL-4pen Clinical Trial
DBLG1 - Pediatric Version
DBLG1 - Pediatric Version Product Overview
Diabeloop SA - Key Competitors
Diabeloop SA - Key Employees
Diabeloop SA - Locations And Subsidiaries
Head Office
Recent Developments
Diabeloop SA, Recent Developments
Mar 21, 2023: Diabeloop Announces Collaboration With Novo Nordisk to Pursue Its Interoperability Strategy With Connected Insulin Pens
Feb 23, 2023: Diabeloop: Launch of a multi-country clinical study in adolescents and young adults with T1D
Sep 21, 2022: 12-month real-world achievements for Diabeloop's AID
Apr 28, 2022: Diabeloop presents new real-life results of DBLG1 system
Apr 12, 2022: Diabeloop adapts its self-learning, personalized insulin automatization software to be used with insulin pens
Sep 16, 2021: Diabeloop joins the AACE Corporate Advisory Program, Appoints US Scientific Advisors
Jun 02, 2021: DBLG1 self-learning algorithm: Easy to use for optimized and personalized T1D management
Mar 22, 2021: BIOCORP and Diabeloop announce co-development agreement in personalized diabetes management
Mar 19, 2021: BIOCORP and Diabeloop announce co-development agreement in personalized diabetes management
Mar 01, 2021: Diabeloop integrates the Accu-Chek Insight insulin pump from Roche into its Automated Insulin Delivery System
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Diabeloop SA Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Diabeloop SA Pipeline Products by Equipment Type
Table 3: Diabeloop SA Pipeline Products by Indication
Table 4: Diabeloop SA, Key Facts
Table 5: Diabeloop SA, Major Products and Services
Table 6: Diabeloop SA Number of Pipeline Products by Development Stage
Table 7: Diabeloop SA Pipeline Products Summary by Development Stage
Table 8: Diabeloop SA Ongoing Clinical Trials by Trial Status
Table 9: Diabeloop SA Ongoing Clinical Trials Summary
Table 10: Automated Insulin Delivery System - Product Status
Table 11: Automated Insulin Delivery System - Product Description
Table 12: DBL-4pen - Product Status
Table 13: DBL-4pen - Product Description
Table 14: DBL-4pen - Multicentric Before/After Study to Assess the Efficacy and Safety of DBL-4pen Mobile Application on Glycemic Control in Patients With Type 2 Diabetes
Table 15: DBLG1 - Pediatric Version - Product Status
Table 16: DBLG1 - Pediatric Version - Product Description
Table 17: Diabeloop SA, Key Employees
Table 18: Glossary
List of Figures
Figure 1: Diabeloop SA Pipeline Products by Equipment Type
Figure 2: Diabeloop SA Pipeline Products by Development Stage
Figure 3: Diabeloop SA Ongoing Clinical Trials by Trial Status

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us